您的位置: 首页 > 农业专利 > 详情页

Composition for being internalized by enzyme and method
专利权人:
REGENERON PHARMACEUTICALS; INC.
发明人:
ANDREW BAIK,KATHERINE CYGNAR
申请号:
BR112018011474
公开号:
BR112018011474A2
申请日:
2016.12.08
申请国别(地区):
BR
年份:
2018
代理人:
摘要:
The invention discloses the compositions and method for treating lysosomal storage disease.The invention discloses the biotherapeutic compounds that enzymatic activity is substituted containing internalization effect object binding structural domain and lysosome.Biotherapeutic compounds can enter cell, be isolated in lysosome, and be delivered to lysosome by enzymatic activity is substituted.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充